Role of the peroxisome proliferator-activated receptor α in responses to dilsononyl phthalate

被引:27
|
作者
Valles, EG [1 ]
Laughter, AR [1 ]
Dunn, CS [1 ]
Cannelle, S [1 ]
Swanson, CL [1 ]
Cattley, RC [1 ]
Corton, JC [1 ]
机构
[1] CIIT Ctr Hlth Res, Res Triangle Pk, NC 27709 USA
关键词
PPAR alpha; peroxisome proliferation; diisononyl phthalate; transcript profiling; hepatocarcinogenesis;
D O I
10.1016/S0300-483X(03)00260-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diisononyl phthalate (DINP) is a compound widely used as a plasticizer in the production of polyvinyl chloride products. Chronic exposure to DINP leads to liver cancer in rats and mice. Many phthalates are considered to be relatively weak peroxisome proliferators (PP), a group of rodent hepatocarcinogens that cause a variety of adaptive responses in liver through the PP-activated receptor alpha (PPARalpha). The objectives of this study were to determine whether DINP-induced effects in the liver associated with carcinogenesis are mediated by PPARalpha and to identify novel gene targets of DINP, Male and female SV129 wild-type, SV129 PPARalpha-null, and B6C3F1 mice were administered DINP by gavage or in the feed. Transcript profile technology and reverse transcriptase (RT)-polymerase chain reaction (PCR) were used to identify gene targets. Dose-dependent increases in relative liver weights were dependent on PPARalpha in 10- or 12-week-old male and female mice and 30-week-old male mice. Female 30-week-old mice exhibited PPARalpha-independent increases in relative liver weights. Increases in hepatocyte proliferation, palmitoyl-CoA oxidase (PCO) activity, and levels of enzymes involved in beta- and omega-oxidation of fatty acids were shown to be dependent on PPARa. Five novel genes were shown to be altered in the livers of female wild-type mice after a 3-week exposure, but not in PPARalpha-mill, mice. These genes included those involved in DNA repair and recombination (ATP-dependent helicase and Endonuclease III homolog), drug metabolism (Cyp2a4) and protein trafficking (FKBP-1, FKBP-13). An additional gene (Cyp2d9) was shown to be down-regulated in wild-type mice but up-regulated in PPARalpha-null mice indicating more complex regulation by PPARalpha and additional factors. These data support the hypothesis that PPARalpha plays a dominant role in mediating the effects associated with hepatocarcinogenesis after DINP exposure. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:211 / 225
页数:15
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis
    von Knethen, Andreas
    Soller, Mathias
    Bruene, Bernhard
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2007, 55 (01) : 19 - 25
  • [43] Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis
    Andreas von Knethen
    Mathias Soller
    Bernhard Brüne
    Archivum Immunologiae et Therapiae Experimentalis, 2007, 55 : 19 - 25
  • [44] Evolution of peroxisome proliferator-activated receptor agonists
    Chang, Feng
    Jaber, Linda A.
    Berlie, Helen D.
    O'Connell, Mary Beth
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (06) : 973 - 983
  • [45] Peroxisome proliferator-activated receptor γ in diabetes and metabolism
    Rangwala, SM
    Lazar, MA
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (06) : 331 - 336
  • [46] PHYSIOLOGICAL FUNCTIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR β
    Neels, Jaap G.
    Grimaldi, Paul A.
    PHYSIOLOGICAL REVIEWS, 2014, 94 (03) : 795 - 858
  • [47] Peroxisome proliferator-activated receptor-γ and lipodystrophy
    Tantsma, Jouke T.
    Rabelink, Ton J.
    FUTURE LIPIDOLOGY, 2006, 1 (04): : 455 - 462
  • [48] ENANTIOSELECTIVE ACTIVATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR
    BOIE, Y
    ADAM, M
    RUSHMORE, TH
    KENNEDY, BP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (08) : 5530 - 5534
  • [49] Peroxisome proliferator-activated receptor γ in malignant diseases
    Wang, TT
    Xu, J
    Yu, XF
    Yang, RC
    Han, ZC
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (01) : 1 - 14
  • [50] Leptin and peroxisome proliferator-activated receptor gamma
    Kim, Y. S.
    Kim, H. H.
    Kang, Y. K.
    Moon, J. S.
    Kwon, S. O.
    Oh, M. K.
    Cha, I. H.
    Kim, S. Y.
    Kim, J. N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 110 - 110